Monte Rosa Therapeutics, Inc. (GLUE) Net margin 2024–2025
Monte Rosa Therapeutics, Inc. (GLUE) net profit margin by fiscal year — reported net income divided by reported revenue.
-58.8%FY2025 · since FY2024: -179.0% → -58.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -58.8% | +120.2 pp |
| FY2024 | -179.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice